 |
Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 11: November 2007
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. 
ACARBOSE
TABLET; ORAL
PRECOSE
>D> + BAYER PHARMS 100MG N20482 002 Sep 06, 1995 Nov CRLD
>A> 100MG N20482 002 Sep 06, 1995 Nov CRLD
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
TABLET; ORAL
OXYCODONE AND ACETAMINOPHEN
>A> AA INTERPHARM 325MG;5MG N40777 001 Nov 27, 2007 Nov NEWA
>A> AA 325MG;10MG N40778 001 Nov 27, 2007 Nov NEWA
>A> AA 500MG;7.5MG N40789 001 Nov 27, 2007 Nov NEWA
>A> AA 650MG;10MG N40789 002 Nov 27, 2007 Nov NEWA
ACETYLCYSTEINE
SOLUTION; INHALATION, ORAL
ACETYLCYSTEINE
>D> AN HOSPIRA 10% N71364 001 May 01, 1989 Nov DISC
>A> @ 10% N71364 001 May 01, 1989 Nov DISC
>D> AN 20% N71365 001 May 01, 1989 Nov DISC
>A> @ 20% N71365 001 May 01, 1989 Nov DISC
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
AMIODARONE HYDROCHLORIDE
>D> AP + HOSPIRA 50MG/ML N76108 001 Oct 15, 2002 Nov DISC
>A> @ 50MG/ML N76108 001 Oct 15, 2002 Nov DISC
AMLODIPINE BESYLATE
TABLET; ORAL
AMLODIPINE BESYLATE
>A> AB CARACO EQ 2.5MG BASE N78231 001 Nov 30, 2007 Nov NEWA
>A> AB EQ 5MG BASE N78231 002 Nov 30, 2007 Nov NEWA
>A> AB EQ 10MG BASE N78231 003 Nov 30, 2007 Nov NEWA
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION; ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
>A> AB HIKMA PHARMS 600MG/5ML;EQ 42.9MG BASE/5ML N65373 001 Nov 09, 2007 Nov NEWA
BENZONATATE
CAPSULE; ORAL
BENZONATATE
>D> AB KV PHARM 100MG N40795 001 Oct 31, 2007 Nov CTEC
>A> AA 100MG N40795 001 Oct 31, 2007 Nov CTEC
>D> AB 200MG N40795 002 Oct 31, 2007 Nov CTEC
>A> AA 200MG N40795 002 Oct 31, 2007 Nov CTEC
BETHANECHOL CHLORIDE
TABLET; ORAL
BETHANECHOL CHLORIDE
>A> AA AMNEAL PHARM 5MG N40855 001 Nov 21, 2007 Nov NEWA
>A> AA 10MG N40855 002 Nov 21, 2007 Nov NEWA
>A> AA 25MG N40855 003 Nov 21, 2007 Nov NEWA
>A> AA 50MG N40855 004 Nov 21, 2007 Nov NEWA
CEFOXITIN SODIUM
INJECTABLE; INJECTION
MEFOXIN
>A> @ BIONICHE PHARMA EQ 1GM BASE/VIAL N62757 001 Jan 08, 1987 Nov CAHN
>A> @ EQ 2GM BASE/VIAL N62757 002 Jan 08, 1987 Nov CAHN
>D> @ MERCK EQ 1GM BASE/VIAL N62757 001 Jan 08, 1987 Nov CAHN
>D> @ EQ 2GM BASE/VIAL N62757 002 Jan 08, 1987 Nov CAHN
MEFOXIN IN PLASTIC CONTAINER
>A> + BIONICHE PHARMA EQ 20MG BASE/ML N63182 001 Jan 25, 1993 Nov CAHN
>A> + EQ 40MG BASE/ML N63182 002 Jan 25, 1993 Nov CAHN
>D> + MERCK EQ 20MG BASE/ML N63182 001 Jan 25, 1993 Nov CAHN
>D> + EQ 40MG BASE/ML N63182 002 Jan 25, 1993 Nov CAHN
CEFPODOXIME PROXETIL
TABLET; ORAL
CEFPODOXIME PROXETIL
>A> AB ORCHID HLTHCARE EQ 100MG BASE N65388 001 Nov 14, 2007 Nov NEWA
>A> AB EQ 200MG BASE N65388 002 Nov 14, 2007 Nov NEWA
CEPHALEXIN
CAPSULE; ORAL
KEFLEX
>A> AB LEX PHARMS EQ 250MG BASE N50405 002 Nov CAHN
>A> EQ 333MG BASE N50405 004 May 12, 2006 Nov CAHN
>A> AB EQ 500MG BASE N50405 003 Nov CAHN
>A> + EQ 750MG BASE N50405 005 May 12, 2006 Nov CAHN
>D> AB MIDDLEBROOK EQ 250MG BASE N50405 002 Nov CAHN
>D> EQ 333MG BASE N50405 004 May 12, 2006 Nov CAHN
>D> AB EQ 500MG BASE N50405 003 Nov CAHN
>D> + EQ 750MG BASE N50405 005 May 12, 2006 Nov CAHN
FOR SUSPENSION; ORAL
KEFLEX
>A> @ LEX PHARMS EQ 100MG BASE/ML N50406 003 Nov CAHN
>A> @ EQ 125MG BASE/5ML N50406 001 Nov CAHN
>A> @ EQ 250MG BASE/5ML N50406 002 Nov CAHN
>D> @ MIDDLEBROOK EQ 100MG BASE/ML N50406 003 Nov CAHN
>D> @ EQ 125MG BASE/5ML N50406 001 Nov CAHN
>D> @ EQ 250MG BASE/5ML N50406 002 Nov CAHN
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CIPROFLOXACIN EXTENDED RELEASE
>A> AB ANCHEN PHARMS 212.6MG;287.5MG N78166 002 Nov 27, 2007 Nov NEWA
>A> AB 425.2MG;574.9MG N78166 001 Nov 27, 2007 Nov NEWA
CROMOLYN SODIUM
SOLUTION; INHALATION
CROMOLYN SODIUM
>A> AN PHARMASCIENCE 10MG/ML N75437 001 Apr 21, 2000 Nov CAHN
>D> AN WARRICK PHARMS 10MG/ML N75437 001 Apr 21, 2000 Nov CAHN
CYTARABINE
INJECTABLE; INJECTION
CYTARABINE
>D> AP ABRAXIS PHARM 100MG/ML N76512 001 Jan 15, 2004 Nov CRLD
>A> + 100MG/ML N76512 001 Jan 15, 2004 Nov CRLD
>D> AP + HOSPIRA 100MG/ML N75383 001 Nov 22, 1999 Nov DISC
>A> @ 100MG/ML N75383 001 Nov 22, 1999 Nov DISC
DEXRAZOXANE HYDROCHLORIDE
INJECTABLE; INJECTION
TOTECT
>D> AP + TOPOTARGET EQ 500MG BASE/VIAL N22025 001 Sep 06, 2007 Nov CTEC
>A> + EQ 500MG BASE/VIAL N22025 001 Sep 06, 2007 Nov CTEC
DILTIAZEM HYDROCHLORIDE
INJECTABLE; INJECTION
DILTIAZEM HYDROCHLORIDE
>D> AP HOSPIRA 5MG/ML N75106 001 Apr 29, 1999 Nov DISC
>A> @ 5MG/ML N75106 001 Apr 29, 1999 Nov DISC
ENALAPRILAT
INJECTABLE; INJECTION
ENALAPRILAT
>D> AP HOSPIRA 1.25MG/ML N75571 001 Aug 22, 2000 Nov DISC
>A> @ 1.25MG/ML N75571 001 Aug 22, 2000 Nov DISC
EPINEPHRINE
INJECTABLE; IM-SC
>D> TWINJECT
>D> + VERUS PHARMS EQ 0.15MG /DELIVERY N20800 002 May 28, 2004 Nov CTNA
>A> TWINJECT 0.15
>A> + VERUS PHARMS EQ 0.15MG /DELIVERY N20800 002 May 28, 2004 Nov CTNA
EPIRUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
EPIRUBICIN HYDROCHLORIDE
>A> AP GENERAMEDIX 50MG/25ML (2MG/ML) N65371 001 Nov 28, 2007 Nov NEWA
>A> AP 200MG/100ML (2MG/ML) N65371 002 Nov 28, 2007 Nov NEWA
ESTRADIOL
GEL, METERED; TRANSDERMAL
ELESTRIN
>D> BX + BRADLEY PHARMS 0.06% N21813 001 Dec 15, 2006 Nov CPOT
>A> BX + 0.06% (0.87GM/ACTIVATION) N21813 001 Dec 15, 2006 Nov CPOT
ESTROGEL
>D> BX + ASCEND 0.06% N21166 002 Feb 09, 2004 Nov CPOT
>A> BX + 0.06% (1.25GM/ACTIVATION) N21166 002 Feb 09, 2004 Nov CPOT
ESTRADIOL HEMIHYDRATE
EMULSION; TOPICAL
ESTRASORB
>A> + ALLERGAN 0.25% N21371 001 Oct 09, 2003 Nov CAHN
>D> + ESPRIT PHARMA 0.25% N21371 001 Oct 09, 2003 Nov CAHN
GABAPENTIN
TABLET; ORAL
GABAPENTIN
>D> AB + IVAX PHARMS 800MG N76017 005 Apr 29, 2005 Nov CRLD
>A> AB 800MG N76017 005 Apr 29, 2005 Nov CRLD
NEURONTIN
>D> AB PFIZER PHARMS 800MG N20882 002 Oct 09, 1998 Nov CRLD
>A> AB + 800MG N20882 002 Oct 09, 1998 Nov CRLD
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
TABLET; ORAL
AVANDARYL
>D> SB PHARMCO 1MG;4MG N21700 001 Nov 23, 2005 Nov CRLD
>A> + 1MG;4MG N21700 001 Nov 23, 2005 Nov CRLD
>D> + 4MG;4MG N21700 003 Nov 23, 2005 Nov CRLD
>A> 4MG;4MG N21700 003 Nov 23, 2005 Nov CRLD
GLYBURIDE; METFORMIN HYDROCHLORIDE
TABLET; ORAL
GLYBURIDE AND METFORMIN HYDROCHLORIDE
>A> AB AUROBINDO 1.25MG;250MG N77870 001 Nov 14, 2007 Nov NEWA
>A> AB 2.5MG;500MG N77870 002 Nov 14, 2007 Nov NEWA
>A> AB 5MG;500MG N77870 003 Nov 14, 2007 Nov NEWA
HALOPERIDOL
TABLET; ORAL
HALOPERIDOL
>D> SANDOZ 20MG N71211 001 Mar 11, 1988 Nov CTEC
>A> AB 20MG N71211 001 Mar 11, 1988 Nov CTEC
>A> AB ZYDUS PHARMS USA 5MG N77580 003 Nov 29, 2007 Nov NEWA
>A> AB 10MG N77580 004 Nov 29, 2007 Nov NEWA
>A> AB 20MG N77580 005 Nov 29, 2007 Nov NEWA
HYDROCHLOROTHIAZIDE
CAPSULE; ORAL
HYDROCHLOROTHIAZIDE
>A> AB WEST WARD 12.5MG N77885 001 Nov 26, 2007 Nov NEWA
HYDROMORPHONE HYDROCHLORIDE
TABLET; ORAL
DILAUDID
>A> AB ABBOTT 2MG N19892 003 Nov 09, 2007 Nov NEWA
>A> AB 4MG N19892 002 Nov 09, 2007 Nov NEWA
IBUPROFEN; OXYCODONE HYDROCHLORIDE
TABLET; ORAL
COMBUNOX
>D> + FOREST LABS 400MG;5MG N21378 001 Nov 26, 2004 Nov CFTG
>A> AB + 400MG;5MG N21378 001 Nov 26, 2004 Nov CFTG
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
>A> AB BARR 400MG;5MG N78316 001 Nov 29, 2007 Nov NEWA
>A> AB WATSON LABS 400MG;5MG N78394 001 Nov 26, 2007 Nov NEWA
INDOCYANINE GREEN
INJECTABLE; INJECTION
IC-GREEN
>D> + AKORN 25MG/VIAL N11525 001 Nov CFTG
>A> AP + 25MG/VIAL N11525 001 Nov CFTG
>A> INDOCYANINE GREEN
>A> AP PULSION MEDCL 25MG/VIAL N40811 001 Nov 21, 2007 Nov NEWA
IPRATROPIUM BROMIDE
SOLUTION; INHALATION
IPRATROPIUM BROMIDE
>A> AN PHARMASCIENCE 0.02% N75507 001 Jan 19, 2001 Nov CAHN
>D> AN WARRICK PHARMS 0.02% N75507 001 Jan 19, 2001 Nov CAHN
LABETALOL HYDROCHLORIDE
INJECTABLE; INJECTION
LABETALOL HYDROCHLORIDE
>D> AP HOSPIRA 5MG/ML N75242 001 Sep 30, 1999 Nov DISC
>A> @ 5MG/ML N75242 001 Sep 30, 1999 Nov DISC
>D> TRANDATE
>D> AP + PROMETHEUS 5MG/ML N19425 001 Dec 31, 1985 Nov DISC
>A> @ 5MG/ML N19425 001 Dec 31, 1985 Nov DISC
LACTULOSE
SOLUTION; ORAL
LACTULOSE
>A> AA ANI PHARMS INC 10GM/15ML N78430 001 Nov 28, 2007 Nov NEWA
LINDANE
LOTION; TOPICAL
LINDANE
>D> AT + ACTAVIS MID 1% N87313 001 Nov DISC
>A> @ 1% N87313 001 Nov DISC
>D> AT MORTON GROVE 1% N88190 001 Aug 16, 1984 Nov CRLD
>A> + 1% N88190 001 Aug 16, 1984 Nov CRLD
LOPINAVIR; RITONAVIR
TABLET; ORAL
KALETRA
>A> ABBOTT 100MG;25MG N21906 002 Nov 09, 2007 Nov NEWA
METOCLOPRAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION
METOCLOPRAMIDE HYDROCHLORIDE
>D> AP HOSPIRA EQ 5MG BASE/ML N71291 001 Mar 03, 1989 Nov DISC
>A> @ EQ 5MG BASE/ML N71291 001 Mar 03, 1989 Nov DISC
>D> AP EQ 5MG BASE/ML N70847 001 Nov 07, 1988 Nov DISC
>A> @ EQ 5MG BASE/ML N70847 001 Nov 07, 1988 Nov DISC
SOLUTION; ORAL
>D> METOCLOPRAMIDE
>D> AA + JVL EQ 5MG BASE/5ML N74703 001 Oct 31, 1997 Nov CTNA
METOCLOPRAMIDE HYDROCHLORIDE
>A> AA ANI PHARMS INC EQ 5MG BASE/5ML N71402 001 Jun 25, 1993 Nov CAHN
>A> AA + JVL EQ 5MG BASE/5ML N74703 001 Oct 31, 1997 Nov CTNA
>D> AA PHARM VENTURES EQ 5MG BASE/5ML N71402 001 Jun 25, 1993 Nov CAHN
TABLET; ORAL
>D> METOCLOPRAMIDE
>D> AB VINTAGE PHARMS EQ 5MG BASE N77878 001 Aug 28, 2006 Nov CTNA
>D> AB EQ 10MG BASE N77878 002 Aug 28, 2006 Nov CTNA
METOCLOPRAMIDE HYDROCHLORIDE
>A> AB NORTHSTAR EQ 5MG BASE N78374 001 Nov 30, 2007 Nov NEWA
>A> AB EQ 10MG BASE N78374 002 Nov 30, 2007 Nov NEWA
>A> AB VINTAGE PHARMS EQ 5MG BASE N77878 001 Aug 28, 2006 Nov CTNA
>A> AB EQ 10MG BASE N77878 002 Aug 28, 2006 Nov CTNA
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HYDROCHLORIDE
>D> AP HOSPIRA EQ 5MG BASE/ML N75484 001 Jun 20, 2000 Nov DISC
>A> @ EQ 5MG BASE/ML N75484 001 Jun 20, 2000 Nov DISC
>D> AP EQ 5MG BASE/ML N75396 002 Jun 20, 2000 Nov DISC
>A> @ EQ 5MG BASE/ML N75396 002 Jun 20, 2000 Nov DISC
MILRINONE LACTATE
INJECTABLE; INJECTION
MILRINONE LACTATE
>D> AP HOSPIRA EQ 1MG BASE/ML N75830 001 May 28, 2002 Nov DISC
>A> @ EQ 1MG BASE/ML N75830 001 May 28, 2002 Nov DISC
MOMETASONE FUROATE
LOTION; TOPICAL
MOMETASONE FUROATE
>A> AB ALTANA 0.1% N75919 001 Nov 29, 2007 Nov NEWA
>A> AB G AND W LABS 0.1% N77678 001 Nov 21, 2007 Nov NEWA
>A> AB TOLMAR 0.1% N76499 001 Nov 21, 2007 Nov NEWA
NEOMYCIN SULFATE
POWDER; FOR RX COMPOUNDING
NEO-RX
>D> X GEN PHARMS 100% N61579 001 Nov CRLD
>A> + 100% N61579 001 Nov CRLD
NIFEDIPINE
CAPSULE; ORAL
NIFEDIPINE
>A> AB CATALENT 10MG N73250 001 Oct 08, 1991 Nov CAHN
>A> AB 20MG N74045 001 Apr 30, 1992 Nov CAHN
>D> AB SCHERER RP 10MG N73250 001 Oct 08, 1991 Nov CAHN
>D> AB 20MG N74045 001 Apr 30, 1992 Nov CAHN
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
>D> AP HOSPIRA EQ 0.64MG BASE/ML N76978 001 Feb 26, 2007 Nov DISC
>A> @ EQ 0.64MG BASE/ML N76978 001 Feb 26, 2007 Nov DISC
SOLUTION; ORAL
ONDANSETRON HYDROCHLORIDE
>A> AA AUROBINDO EQ 4MG BASE/5ML N78776 001 Nov 28, 2007 Nov NEWA
>A> AA TARO EQ 4MG BASE/5ML N77009 001 Nov 30, 2007 Nov NEWA
OXCARBAZEPINE
TABLET; ORAL
OXCARBAZEPINE
>A> AB TARO 150MG N77801 001 Nov 15, 2007 Nov NEWA
>A> AB 300MG N77801 002 Nov 15, 2007 Nov NEWA
>A> AB 600MG N77801 003 Nov 15, 2007 Nov NEWA
PACLITAXEL
INJECTABLE; INJECTION
PACLITAXEL
>D> AP HOSPIRA 6MG/ML N76233 001 Aug 01, 2002 Nov DISC
>A> @ 6MG/ML N76233 001 Aug 01, 2002 Nov DISC
PANTOPRAZOLE SODIUM
>A> GRANULE, DELAYED RELEASE; ORAL
>A> PROTONIX
>A> + WYETH PHARMS EQ 40MG BASE N22020 001 Dec 14, 2007 Nov NEWA
PHENYTOIN SODIUM
INJECTABLE; INJECTION
PHENYTOIN SODIUM
>A> AP PHARMAFORCE 50MG/ML N40781 001 Dec 04, 2007 Nov NEWA
SEVOFLURANE
LIQUID; INHALATION
SEVOFLURANE
>A> AN HALOCARBON 100% N78650 001 Nov 19, 2007 Nov NEWA
TESTOSTERONE
GEL; TRANSDERMAL
TESTIM
>D> BX + AUXILIUM PHARMS 1% N21454 001 Oct 31, 2002 Nov CPOT
>A> BX + 1% (5GM/PACKET) N21454 001 Oct 31, 2002 Nov CPOT
TRAMADOL HYDROCHLORIDE
TABLET; ORAL
TRAMADOL HYDROCHLORIDE
>A> AB AMNEAL PHARMS 50MG N76003 001 Jun 20, 2002 Nov CAHN
>D> AB COREPHARMA 50MG N76003 001 Jun 20, 2002 Nov CAHN
TRIAMCINOLONE ACETONIDE
>A> INJECTABLE; INTRAVITREAL
>A> TRIESENCE
>A> + ALCON 40MG/ML (40MG/ML) N22048 001 Nov 29, 2007 Nov NEWA
VALPROIC ACID
CAPSULE; ORAL
VALPROIC ACID
>A> AB CATALENT 250MG N73229 001 Oct 29, 1991 Nov CAHN
>D> AB SCHERER RP 250MG N73229 001 Oct 29, 1991 Nov CAHN
CETIRIZINE HYDROCHLORIDE
>A> SYRUP; ORAL
>A> CHILDREN'S ZYRTEC ALLERGY
>A> + PFIZER 1MG/ML N22155 002 Nov 16, 2007 Nov NEWA
>A> CHILDREN'S ZYRTEC HIVES RELIEF
>A> + PFIZER 1MG/ML N22155 001 Nov 16, 2007 Nov NEWA
>A> TABLET, CHEWABLE; ORAL
>A> CHILDREN'S ZYRTEC ALLERGY
>A> PFIZER 5MG N21621 003 Nov 16, 2007 Nov NEWA
>A> + 10MG N21621 004 Nov 16, 2007 Nov NEWA
>A> CHILDREN'S ZYRTEC HIVES RELIEF
>A> PFIZER 5MG N21621 005 Nov 16, 2007 Nov NEWA
>A> + 10MG N21621 006 Nov 16, 2007 Nov NEWA
>A> TABLET; ORAL
>A> ZYRTEC ALLERGY
>A> PFIZER 5MG N19835 003 Nov 16, 2007 Nov NEWA
>A> + 10MG N19835 004 Nov 16, 2007 Nov NEWA
>A> ZYRTEC HIVES RELIEF
>A> PFIZER 5MG N19835 005 Nov 16, 2007 Nov NEWA
>A> + 10MG N19835 006 Nov 16, 2007 Nov NEWA
>A> CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
>A> TABLET, EXTENDED RELEASE; ORAL
>A> ZYRTEC-D 12 HOUR
>A> + PFIZER 5MG;120MG N21150 002 Nov 09, 2007 Nov NEWA
MINOXIDIL
SOLUTION; TOPICAL
THEROXIDIL
>A> HARMONY LABS 2% N78176 001 Nov 09, 2007 Nov NEWA
RANITIDINE HYDROCHLORIDE
TABLET; ORAL
RANITIDINE
>A> WOCKHARDT EQ 150MG BASE N78653 001 Nov 26, 2007 Nov NEWA
 Back
to Top 
Back to Additions/Deletions Index
Date created: December 11, 2007 |
|
